MarginsXMarginsX
Home › Markets › Health Care › ASBP

Aspire-Lakewood Holdings Inc. (ASBP)

ASBP trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$8.06
-5.29% on the day
Market cap
$11.3M
Nano cap
Revenue · 2025
$6K
No prior year to compare
Net income · 2025
-$24.5M
-394725.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K/A (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1847345/000149315226015737/0001493152-26-015737-index.htm. Net income: SEC 10-K/A (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerASBP on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2022
SEC CIK0001847345
SEC industry codePharmaceutical Preparations
Incorporated inCayman Islands

Financials · 2025

LineValue
Revenue$6K
Net income-$24.5M
Operating income-$19.4M
Net margin-394725.1%
Operating margin-312016.9%
Revenue growthNo prior-year revenue to compare
Cash$1.0M
Total assets$1.3M
P/E (computed)Net income was not positive
P/S (computed)1822.7×

Warning signs

Cash runway
20.3 months
$12.2M cash at June 30, 2026
Share count, 1 year
+13.3%
2025-08-12 to 2026-08-07
Going-concern doubt
No
10-Q filed August 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-13
Cash and burn$12.2M cash; operating cash flow -$1.8M a quarter.Report 2026-06-30
Shares outstanding1,402,557 (2026-08-07); 49,525,970 a year earlier. 1y figure adjusted for split (1-for-40 overall).Cover page 2026-08-07
Reverse splits, 3 years1; latest 1-for-40 on 2026-01-16Source 2026-01-16
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-02-19
AuditorTurner, Stone & Company, L.L.P., Dallas, Texas, United States; changed auditors 3 times in 24 months8-K 4.01 2026-09-29
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$63K-$1.3M-$2.1M$12.2MNo debt tags$98K10-Q 2026-08-13
Q1 2026
2026-03-31
$28K-$3.2M-$3.0M$5.9MNo debt tagsNeeds four quarters10-Q 2026-05-15
Q4 2025
2025-12-31
$4K-$4.7M-$928K$1.0M$1.4M$6K10-K/A 2026-04-08
Q3 2025
2025-09-30
$2K-$1.9M-$1.1M$1.9M$8.5MNeeds four quarters10-Q 2025-11-14
Q2 2025
2025-06-30
Not filed-$2.0M-$1.1M$206K$5.4MNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$15.9M-$1.8M$1.3M$4.9MNeeds four quarters10-Q 2026-08-13
Q4 2024
2024-12-31
Not filed-$766K$480K$4K$1.3MNeeds four quarters10-Q 2025-11-14
Q3 2024
2024-09-30
Not filed-$216K-$496K$17KNo debt tagsNeeds four quarters10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-1/A2026-04-10
Latest annual report10-K/A2026-04-08
Latest quarterly / interim10-Q2026-08-13
Latest current report8-K/A2026-10-20
Latest proxyDEF 14A2026-05-08

Source: SEC EDGAR submissions feed, 230 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.0%
1 month+2.8%
3 months+18.3%
Year to date+59.3%
1 year+100.2%
From 52-week high-9.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
ASBPWAspire-Lakewood Holdings Inc. Warrant$0.0117

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
DAREDare Bioscience Inc.$0.5842-11.13%$11.5M
RADXRadiopharm Theranostics Limited$0.7676+1.00%$11.1M
BIVIBioVie Inc.$1.08-4.42%$11.6M
PTNPalatin Technologies Inc.$6.13-1.69%$10.9M
LSTALisata Therapeutics Inc.$1.09-9.92%$11.8M
HINDVyome Holdings Inc.$1.53-3.16%$10.7M
QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares$1.44-10.56%$12.2M
OPTHOptimi Health Corp. Common Shares$2.15-4.44%$12.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier